HomeERMA • STO
add
Enorama Pharma AB
Previous close
kr 2.80
Year range
kr 1.52 - kr 4.99
Market cap
208.85M SEK
Avg Volume
4.90K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 734.00K | -87.02% |
Operating expense | 12.86M | 43.89% |
Net income | -18.71M | -176.46% |
Net profit margin | -2.55K | -2,030.37% |
Earnings per share | — | — |
EBITDA | -15.18M | -168.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.52M | -85.51% |
Total assets | 24.99M | -49.74% |
Total liabilities | 16.71M | 52.38% |
Total equity | 8.28M | — |
Shares outstanding | 67.14M | — |
Price to book | 23.33 | — |
Return on assets | -126.78% | — |
Return on capital | -436.11% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -18.71M | -176.46% |
Cash from operations | -7.19M | 42.96% |
Cash from investing | — | — |
Cash from financing | 2.98M | -88.31% |
Net change in cash | -2.13M | -116.15% |
Free cash flow | -3.81M | 62.01% |
About
Founded
2006
Website
Employees
5
